Biomarkers of tumor-reactive CD4 + and CD8 + TILs associate with improved prognosis in endometrial cancer.
Jara PalomeroCarla PaniselloMaria Lozano-RabellaRicky TirtakasumaJudit Díaz-GómezDaniela GrasesHelena PasamarLaura ArreguiEduard Dorca DuchEsther Guerra FernándezAna VivancosCarlos E de AndreaIgnacio Melero BermejoJordi PonceAugust VidalJosep Maria PiulatsXavier Matias-GuiuAlena GrosPublished in: Journal for immunotherapy of cancer (2023)
lymphocytes, hold prognostic value suggesting their protective role in antitumor immunity.